These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26861782)

  • 1. Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program.
    Walford GA; Ma Y; Clish C; Florez JC; Wang TJ; Gerszten RE;
    Diabetes; 2016 May; 65(5):1424-33. PubMed ID: 26861782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
    Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
    Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
    Kim C; Christophi CA; Goldberg RB; Perreault L; Dabelea D; Marcovina SM; Pi-Sunyer X; Barrett-Connor E
    Diabet Med; 2016 Jan; 33(1):32-8. PubMed ID: 25970741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.
    Merlotti C; Morabito A; Pontiroli AE
    Diabetes Obes Metab; 2014 Aug; 16(8):719-27. PubMed ID: 24476122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
    Diabetes Prevention Program Research Group
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
    Orchard TJ; Temprosa M; Goldberg R; Haffner S; Ratner R; Marcovina S; Fowler S;
    Ann Intern Med; 2005 Apr; 142(8):611-9. PubMed ID: 15838067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.
    Herman WH; Pan Q; Edelstein SL; Mather KJ; Perreault L; Barrett-Connor E; Dabelea DM; Horton E; Kahn SE; Knowler WC; Lorenzo C; Pi-Sunyer X; Venditti E; Ye W;
    Diabetes Care; 2017 Dec; 40(12):1668-1677. PubMed ID: 29021207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.
    Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
    Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypoglycemia in the Look AHEAD Trial.
    ; Greenway FL
    J Diabetes Complications; 2016 Jul; 30(5):935-43. PubMed ID: 27114389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program.
    O'Brien MJ; Whitaker RC; Yu D; Ackermann RT
    Prev Med; 2015 Aug; 77():125-30. PubMed ID: 26024851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM; Schlessinger L; Kahn R
    Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early weight-loss success identifies nonresponders after a lifestyle intervention in a worksite diabetes prevention trial.
    Miller CK; Nagaraja HN; Weinhold KR
    J Acad Nutr Diet; 2015 Sep; 115(9):1464-71. PubMed ID: 26095435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions.
    Goldberg RB; Bray GA; Marcovina SM; Mather KJ; Orchard TJ; Perreault L; Temprosa M;
    Diabetologia; 2019 Jan; 62(1):58-69. PubMed ID: 30334082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of comprehensive lifestyle intervention or metformin on obesity in young women.
    Lim SS; Norman RJ; Clifton PM; Noakes M
    Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):261-8. PubMed ID: 20163941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PREVIEW (Prevention of Diabetes Through Lifestyle Intervention and Population Studies in Europe and Around the World) study in children aged 10 to 17 years: Design, methods and baseline results.
    Dorenbos E; Drummen M; Rijks J; Adam T; Stouthart P; Alfredo Martínez J; Navas-Carretero S; Stratton G; Swindell N; Fogelholm M; Raben A; Westerterp-Plantenga M; Vreugdenhil A
    Diabetes Obes Metab; 2018 May; 20(5):1096-1101. PubMed ID: 29322617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
    Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
    Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.